Oral ingestion of Verisol collagen peptides lead to a pronounced, statistically significant reduction of eye wrinkle volume. This is the result of a recently published study by the University of Kiel Germany focusing on the effect of these Bioactive Collagen Peptides (BCP) on human skin conditions.
Sponsored Links Acute Pain Management Training
“There is a direct impact on dermal extracellular matrix turnover,” stated Dr Stephan Hausmanns, vice president Business Unit Health & Nutrition. “This is clearly demonstrated by a significant increase in collagen and elastin synthesis, with the result of statistically significant wrinkle reduction after only 4, and even more pronounced after 8 weeks of treatment. In simple words: the participants looked considerably younger after the treatment.”
This study completes the results from a previous Verisol study proving the effect of Verisol on skin elasticity. Together the results of the two studies provide a sound scientific foundation for the development of innovative nutricosmetics, which are used by a growing consumer group to complement topical applications and follow a more holistic approach to skin care.
After 4 weeks of treatment the BCP group showed a statistically significantly reduced eye wrinkle volume of more than 7.2% on average. This positive effect was more pronounced after 8 weeks of intake (20.1%).
Four weeks after the last product intake (4-week regression phase), the BCP treatment group still showed a statistically significant decrease in eye wrinkle volume of 11.5%.
Pro-collagen type I content was increased by 65%, elastin by 18% and fibrillin by 6% after 8 weeks of BCP treatment.
